Personalis shares rose after the company received Medicare coverage for its NeXT Personal molecular residual disease test for surveillance of patients with Stage I to III non-small cell lung cancer.

BBI WBC Rosters Baseball FILE - New York Mets' Francisco Lindor walks to the dugout during a baseball game against the Miami Marlins, Saturday, Sept. 27, 2025, in ...

The pilots in a deadly business jet crash in Michigan were performing a test flight themselves, following repairs, instead of waiting for a test pilot, when the aircraft plunged into woods near ...

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for ...

Mojang Studios announced Tuesday it will eliminate code obfuscation in Minecraft: Java Edition, marking a significant shift in how the company distributes the game to its modding community. The change ...

Abstract: Code coverage analysis has been widely adopted in the continuous integration of open-source and industry software repositories to monitor the adequacy of regression test suites. However, ...

The NBA has new broadcast partners this season in Amazon and NBC. So far fans have overwhelmingly approved of Peacock and Prime's fresh new takes on basketball coverage. New faces, new voices, new ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

Traditional Medicare will face greater use of prior authorizations under a pilot program by the Centers for Medicare & Medicaid Services, potentially eroding one area that enrollees like about their ...

Increasing prior authorizations would 'undercut one of the immense benefits of traditional Medicare' Traditional Medicare currently faces fewer prior authorizations than Medicare Advantage, but that ...

Natera, Inc.'s revenue growth remains strong, driven by rapid adoption of Signatera, now covered by Medicare, which should provide recurring revenue and some competitive advantage. Litigation risks ...